The Directorate of Drugs Control, Punjab, has issued an urgent recall alert, ordering the immediate suspension of sale and use of certain batches of Injection SATAMIN (mecobalamin JP 500 mcg) after they were declared substandard and adulterated.
In an official notification, the Directorate directed all retailers, wholesalers, and distributors to stop dispensing the affected injections immediately.
Stakeholders have also been instructed to report existing stock levels and consumption records to their respective area drug inspectors without delay.
Recall Ordered Following Laboratory Findings
According to the Directorate, the Drug Testing Laboratories Punjab flagged the medicine as substandard. Following these findings, the Provincial Quality Control Board ordered an immediate recall from the market to protect public health.
Affected Injection SATAMIN Batches
The recall applies to the following batches of Injection SATAMIN, Reg. No.: 071284:
-
Batch No MC24-022 – Expiry: July 2026
-
Batch No MC24-023 – Expiry: June 2026
-
Batch No MC24-026 – Expiry: July 2026
-
Batch No MC25-001 – Expiry: July 2027
The manufacturer has been instructed to ensure the complete withdrawal of these batches from the market. Authorities warned that strict compliance with the recall order is mandatory.
Public Health Safety Emphasized
The Directorate stressed that the recall is a precautionary measure to safeguard public health and prevent the use of compromised pharmaceutical products. Patients and healthcare providers are urged to check their stocks and report any usage of the affected batches immediately.
